Comparison of Immune Profiles in Fetal Hearts with Idiopathic Dilated Cardiomyopathy, Maternal Autoimmune-Associated Dilated Cardiomyopathy and the Normal Fetus

Pediatric Cardiology

Volumn 37, Issue 2, 2016, Pages 353-363

  Nield, Lynne E ^a   von Both, Ingo ^b   Popel, Najla ^b   Strachan, Kate ^c   Manlhiot, Cedric ^a   Shannon, Patrick ^c   McCrindle, Brian W ^a   Atkinson, Adelle ^a   Miner, Steven E S ^b   Jaeggi, Edgar T ^a   Taylor, Glenn P ^a,c  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

Author keywords

Cardiomyopathy; Endocardial fibroelastosis; Fetus; Immune system; Myocardium

Indexed keywords

BIOLOGICAL MARKER; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; CD7 ANTIGEN; CD79A ANTIGEN; CD8 ANTIGEN;

ARTICLE; AUTOIMMUNE ASSOCIATED DILATED CARDIOMYOPATHY; AUTOIMMUNE DISEASE; AUTOPSY; B LYMPHOCYTE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; FEMALE; FETUS; GESTATION PERIOD; HEART DEVELOPMENT; HUMAN; HUMAN TISSUE; IMMUNOLOGICAL PARAMETERS; MALE; MONOCYTE; NEWBORN; RETROSPECTIVE STUDY; T LYMPHOCYTE; CARDIAC MUSCLE; CASE CONTROL STUDY; CYTOLOGY; FACTUAL DATABASE; FETUS HEART; IMMUNOLOGY; METABOLISM; ONTARIO; PATHOLOGY; STATISTICAL MODEL;

AUTOPSY; B-LYMPHOCYTES; BIOMARKERS; CARDIOMYOPATHY, DILATED; CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; FETAL HEART; HUMANS; INFANT, NEWBORN; LINEAR MODELS; MALE; MYOCARDIUM; ONTARIO; RETROSPECTIVE STUDIES; T-LYMPHOCYTES;

EID: 84959108584     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-015-1284-4     Document Type: Article

References (30)

1. Ahuja P, Sdek P, MacLellan WR (2007) Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol Rev 87:521–544
2. Aoki H, Inamura N, Kawazu Y, Nakayama M, Kayatani F (2011) Fetal echocardiographic assessment of endocardial fibroelastosis in maternal anti-SSA antibody-associated complete heart block. Circu J 75:1215–1221
3. Bacchetta R, Gregori S, Roncarolo MG (2005) CD4+ regulatory T cells: mechanisms of induction and effector function. Autoimmun Rev 4:491–496
4. Bovicelli L, Picchio FM, Pilu G, Baccarani G, Orsini LF, Rizzo N, Alampi G, Benenati PM, Hobbins JC (1984) Prenatal diagnosis of endocardial fibroelastosis. Prenat Diagn 4:67–72
5. Caddell JL (2001) Endomyocardial fibroelastosis. Lippincott Williams & Wilkins, Philadelphia
6. Canter CE, Simpson KP (2014) Diagnosis and treatment of myocarditis in children in the current era. Circulation 129:115–128
7. Cupedo T, Nagasawa M, Weijer K, Blom B, Spits H (2005) Development and activation of regulatory T cells in the human fetus. Eur J Immunol 35:383–390
8. Epelman S, Lavine KJ, Beaudin AE, Sojka DK, Carrero JA, Calderon B, Brija T, Gautier EL, Ivanov S, Satpathy AT, Schilling JD, Schwendener R, Sergin I, Razani B, Forsberg EC, Yokoyama WM, Unanue ER, Colonna M, Randolph GJ, Mann DL (2014) Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity 40:91–104
9. Epelman S, Lavine KJ, Randolph GJ (2014) Origin and functions of tissue macrophages. Immunity 41:21–35
10. Fernandes NM, Taylor GP, Manlhiot C, McCrindle BW, Ho M, Miner SE, Atkinson A, Jaeggi ET, Nield LE (2011) The myocardium of fetuses with endocardial fibroelastosis contains fewer B and T lymphocytes than normal control myocardium. Pediatr Cardiol 32:1088–1095
11. Fishbein MC, Ferrans VJ, Roberts WC (1977) Histologic and ultrastructural features of primary and secondary endocardial fibroelastosis. Arch Pathol Lab Med 101:49–54
12. Foley DA, Edwards WD (1988) Quantitation of leukocytes in endomyocardial tissue from 100 normal human hearts at autopsy. Implications for diagnosis of myocarditis from biopsy specimens of living patients. Am J Cardiovasc Pathol 2:145–149
13. Gadgil A, Duncan SR (2008) Role of T-lymphocytes and pro-inflammatory mediators in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 3:531–541
14. Greenwood RD, Nadas AS, Fyler DC (1976) The clinical course of primary myocardial disease in infants and children. Am Heart J 92:549–560
15. Jaeggi ET, Hamilton RM, Silverman ED, Zamora SA, Hornberger LK (2002) Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution’s experience of 30 years. J Am Coll Cardiol 39:130–137
16. Khalil A, Trehan R, Tiwari A, Malik R, Arora R (1994) Immunological profile in congenital heart disease. Indian Pediatr 31:295–300
17. Kojima M, Nakamura S, Yamane Y, Nishikawa M, Murayama K, Shimizu K, Itoh H, Masawa N (2004) Antigen preservation in infarcted nodal B-cell lymphoma, with special reference to follicular center cell markers. Int J Surg Pathol 12:251–255
18. Kotylo PK, Fineberg NS, Freeman KS, Redmond NL, Charland C (1993) Reference ranges for lymphocyte subsets in pediatric patients. Am J Clin Pathol 100:111–115
19. Kuhl U, Noutsias M, Seeberg B, Schultheiss HP (1996) Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 75:295–300
20. Lee BW, Yap HK, Chew FT, Quah TC, Prabhakaran K, Chan GS, Wong SC, Seah CC (1996) Age- and sex-related changes in lymphocyte subpopulations of healthy Asian subjects: from birth to adulthood. Cytometry 26:8–15
21. Nield LE, Silverman ED, Smallhorn JF, Taylor GP, Mullen JB, Benson LN, Hornberger LK (2002) Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J Am Coll Cardiol 40:796–802
22. Nield LE, Silverman ED, Taylor GP, Smallhorn JF, Mullen JB, Silverman NH, Finley JP, Law YM, Human DG, Seaward PG, Hamilton RM, Hornberger LK (2002) Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis. Circulation 105:843–848
23. Pedra SR, Smallhorn JF, Ryan G, Chitayat D, Taylor GP, Khan R, Abdolell M, Hornberger LK (2002) Fetal cardiomyopathies: pathogenic mechanisms, hemodynamic findings, and clinical outcome. Circulation 106:585–591
24. Rich RR, Fleisher TA, Shearer WT, Schroeder HW, Frew AJ, Weyand CM (2012) Clinical immunology, principles and practice (expert consult—online and print), 4: clinical immunology. Elsevier, Amsterdam
25. Rychik J, Piccoli DA, Barber G (1991) Usefulness of corticosteroid therapy for protein-losing enteropathy after the Fontan procedure. Am J Cardiol 68:819–821
26. Shevach EM (2002) CD4+ CD25 + suppressor T cells: more questions than answers. Nat Rev Immunol 2:389–400
27. Trucco SM, Jaeggi E, Cuneo B, Moon-Grady AJ, Silverman E, Silverman N, Hornberger LK (2011) Use of intravenous gamma globulin and corticosteroids in the treatment of maternal autoantibody-mediated cardiomyopathy. J Am Coll Cardiol 57:715–723
28. Varga I, Pospisilova V, Jablonska-Mestanova V, Galfiova P, Polak S (2011) The thymus: picture review of human thymus prenatal development. Bratisl Lek Listy 112:368–376
29. Yinon Y, Yagel S, Hegesh J, Weisz B, Mazaki-Tovi S, Lipitz S, Achiron R (2007) Fetal cardiomyopathy–in utero evaluation and clinical significance. Prenat Diagn 27:23–28
30. Zellers TM, Brown K (1996) Protein-losing enteropathy after the modified fontan operation: oral prednisone treatment with biopsy and laboratory proved improvement. Pediatr Cardiol 17:115–117